LisaC

[LisaC @lilyhaca]

@DrAttai Narrator: “The journal’s Impact Factor was not high.”

[MarginProbe @MarginProbe]

Poster presentation at #SABC19! @SABCSSanAntonio
https://t.co/KpozJP5sxG

[LisaC @lilyhaca]

Meet us there! #SABCS19

[MarginProbe @MarginProbe]

We're looking forward to presenting our cutting-edge data and expanded technology platform later today at the 2019 San Antonio Breast Cancer Symposium from 5-7 pm, during Poster Session 5, Ongoing Trials, Program # OT3-04-01. @SABCSSanAntonio #SABCS19 https://t.co/KpozJP5sxG

[LisaC @lilyhaca]

What if breast tissue could be characterized at the time of biopsy? #SABCS19 @MarginProbe #breastcancer *happy birthday lori

[LisaC @lilyhaca]

“Everyone needs to understand the impact of not only the first surgery, but if any cancer is missed, the toll it will take on the patient to undergo a second surgical procedure,” - Thank you @ANaikMD for your patient-centered care! @EinsteinHealth #breastcancer

[MarginProbe @MarginProbe]

"Less surgery means she can hopefully get on with her life that much sooner and that’s something you just can’t put a value on," said Dr. Archit Naik when discussing the recent integration of MarginProbe into his standard of care. @EinsteinHealth @ANaikMD https://t.co/8x9BoPpmFL

[MarginProbe @MarginProbe]

In case you missed it, be sure to check out some of our favorite moments from our busiest #BreastCancerAwarenessMonth ever! https://t.co/lYZ7CEUtwi

[MarginProbe @MarginProbe]

Dr. Kerry-Ann McDonald, a breast surgeon at @BocaRegional, focuses on leading-edge technologies like MarginProbe to ensure that she is providing the best oncologic and cosmetic outcomes for her patients. https://t.co/0XlixSyaDJ

[lori.chmura @ChmuraLori]

Nerve preservation during nipple sparing mastectomy, true breakthrough for women needing mastectomy . Congratulations @annepeledmd inspirational! Thanks for your dedication to helping women live their best life post cancer diagnosis. @MarginProbe @tmebcn

[MarginProbe @MarginProbe]

“I, along with the other breast surgeons at Virtua, started using MarginProbe to provide an extra layer of protection for patients,” shared Dr. Elizabeth Revesz, breast surgeon at @VirtuaHealth Breast Care, in her surgeon spotlight. #BreastCancerAwareness https://t.co/2SCgFpTlF9

[LisaC @lilyhaca]

Dr Lorenz from @ClevelandClinic at @NAMCP meeting stresses importance of payers to analyze total cost of care vs short term cost. We agree! #breastcancer #lumpectomy @MarginProbe

[LisaC @lilyhaca]

Supporting @NAMCP meeting and doing our part to bring value to #healthcare #breastcancer @MarginProbe

[MarginProbe @MarginProbe]

Dr. Misti Wilson is excited by the fast-moving developments in her field, including MarginProbe. "It reduces re-excisions and it typically reduces the amount of breast tissue we need to remove." Read more! #BCAM https://t.co/BWc0AffQ0m

[NYU Langone Health @nyulangone]

#WeArePioneers: #Breastcancer surgeon Dr. Freya Schnabel performed the 1st surgery with MarginProbe, which helps scan the outer edges of excised tissue to ensure they are clear of any breast cancer cells & eliminates the need for follow-up procedures. https://t.co/DLzJ6eWsCV

[LisaC @lilyhaca]

Over 14,400 runners for the @MercyCR #EFYrace - we are so proud to work with Dr Reid and support this event! #breastcancerawareness #BreastCancerAwarenessMonth @HallPerrine #breastcancer #lumpectomy

[MarginProbe @MarginProbe]

The 29th annual Especially for You Race Against Breast Cancer yesterday was a huge success! Here are some snapshots from the post-race health fair, where Fiona got to meet up with Dr. Reid and show off our pink probe for #BreastCancerAwarenessMonth. @MercyCR @HallPerrine

[JAMA @JAMA_current]

Patients with small, HER2–positive breast tumors treated with adjuvant paclitaxel and trastuzumab showed persistently high rates of disease-free survival (DFS) after a median follow-up of 6.5 y, reported a recent secondary analysis https://t.co/hDOtWl4DH2

[LisaC @lilyhaca]

"The ability to avoid further disfiguring surgery or a potential mastectomy is just amazing, especially from the patient’s perspective.” Thank you, Dr. Rohatgi. @coordhealth #breastcancer #lumpectomy

[MarginProbe @MarginProbe]

“While my re-excision rate was not as high as what’s quoted in the medical literature, in my mind, nobody should have to go back for another surgery,” said Dr. Rohatgi, breast and general surgeon with @coordhealth. #lumpectomy #breastcancer https://t.co/9hbAVkuYXH

[LisaC @lilyhaca]

I am so fortunate to do what I love, at a place I love to do it. Thank you for this fun project, and the opportunity to discuss someone I care about who is very missed. ♥️ @MarginProbe #breastcancer #lumpectomy

[MarginProbe @MarginProbe]

Get to know Lisa Cadena, Director of Clinical Advocacy and Development, and discover what fuels her passion for #breastcancer care in our first-ever employee spotlight! @lilyhaca https://t.co/sDFpV2wYij

[LisaC @lilyhaca]

@GraceCordovano @chrissyfarr Following you now, this is great!

[LisaC @lilyhaca]

@DrAttai This is so timely, I just spent an hour tonight looking for some very specific data points on DCIS and was surprised how hard it was to find!

[LisaC @lilyhaca]

Johns Hopkins' level of commitment and care to their patients has been inspiring to witness. It is an honor to be partnered with them in the effort to make sure their #breastcancer patients need only one #lumpectomy surgery. Thank you @HopkinsMedicine

[MarginProbe @MarginProbe]

“I know from experience that one of the most difficult conversations with a patient after breast conserving surgery is the one that tells them 'we didn't get it all,'” stated Dr. Mehran Habibi, Medical Director of the Johns Hopkins Breast Center. https://t.co/qx9IxE6QET